Market closedNon-fractional

TransMedics Group/TMDX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About TransMedics Group

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Ticker

TMDX

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Andover, United States

Employees

584

TMDX Metrics

BasicAdvanced
$4.9B
Market cap
-
P/E ratio
-$0.32
EPS
1.87
Beta
-
Dividend rate
$4.9B
1.87
9.723
8.605
322.402
323.71
1.13%
1.85%
-5.79%
16.38
30.63
33.65
-21.13
149.23%
-65.82%
127.67%
-33.21%

What the Analysts think about TMDX

Analyst Ratings

Majority rating from 8 analysts.
Buy

TMDX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
12.50% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$97M
19.36%
Net income
$12M
202.50%
Profit margin
12.50%
153.55%

TMDX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 975.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.03
-$0.78
$0.12
$0.35
-
Expected
-$0.13
-$0.16
-$0.06
-$0.04
$0.20
Surprise
-76.92%
382.47%
-293.55%
-975.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for TransMedics Group stock?

TransMedics Group (TMDX) has a market cap of $4.9B as of July 04, 2024.

What is the P/E ratio for TransMedics Group stock?

The price to earnings (P/E) ratio for TransMedics Group (TMDX) stock is 0 as of July 04, 2024.

Does TransMedics Group stock pay dividends?

No, TransMedics Group (TMDX) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next TransMedics Group dividend payment date?

TransMedics Group (TMDX) stock does not pay dividends to its shareholders.

What is the beta indicator for TransMedics Group?

TransMedics Group (TMDX) has a beta rating of 1.87. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell TransMedics Group stock

Buy or sell TransMedics Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing